Skip to main content
SpringerLink
Log in

Nicorandil suppressed myocardial purine metabolism during exercise in patients with angina pectoris

  • Pharmacodynamics
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

To elucidate the effect of Nicorandil on myocardial energy metabolism and myocardial sympathetic activity, we administered Nicorandil orally to eight patients with angina pectoris prior to exercise testing. Arterial and coronary sinus levels of lactate, ammonia, hypoxanthine (HX), adrenaline and noradrenaline were measured during exercise in order to determine the irrespective myocardial extraction ratios (MER). Compared to placebo, Nicorandil increased the time to development of significant ST depression (322 vs 390 s) while decreasing the maximum amplitude of ST depression (0.244 vs 0.216 mV). Heart rate, systolic blood pressure, and the rate pressure product during exercise were not significantly affected. The MER of lactate, measured during exercise, was significantly higher after Nicorandil than placebo (13.6 vs 27.9). Similarly, the MERs of ammonia and HX were significantly higher after Nicorandil (-46.0 vs 7.4% and −47.0 vs 9.9% respectively). Nicorandil, had no apparent effect on myocardial sympathetic activity as the MERs of adrenaline and noradrenaline were essentially unaffected. We conclude that Nicorandil decreased myocardial ischaemia and suppressed myocardial accelerated purine metabolism (a marker of cellular energy metabolism) during exercise in patients with angina pectoris. This effect appears not to be related to myocardial sympathetic activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Preuss KC, Gross GJ, Brooks HL, Warltier DC (1985) Hemodynamic actions of nicorandil, a new antianginal agent, in the conscious dog. J Cardiovasc Pharmacol 7:709–714

    Google Scholar 

  2. Gross G, Pieper G, Farber NE, Warltier D, Hardman H (1989) Effects of nicorandil on coronary circulation and myocardial ischemia. Am J Cardiol 63:11J-17J

    Google Scholar 

  3. Gross GJ, Auchampach JA, Maruyama M, Warltier D, Pieper GM (1992) Cardioprotective effects of nicorandil. J Cardiovasc Pharmacol 20[Suppl 3]:S22-S28

    Google Scholar 

  4. Norman B, Sollevi A, Kaijser L, Jansson E (1987) ATP breakdown products in human skeletal muscle during prolonged exercise to exhaustion. Clin Physiol 7:503–509

    Google Scholar 

  5. Ketai LH, Simon RH, Kreit JW, Grum CM (1987) Plasma hypoxanthine and exercise Am Rev Respir Dis 136:98–101

    Google Scholar 

  6. Lowenstein JM, Tornheim K (1971) Ammonia production in muscle: the purine nucleotide cycle. Science 171:387–400

    Google Scholar 

  7. Mineo I, Kono N, Hara N, Shimizu T, Yamada Y, Kawachi M, Kiyokawa H, Wang YL, Tarui S (1987) Myogenic hyperuricemia: a common pathophysiologic feature of glycogenesis type III, V, and VII. N Engl J Med 317:75–80

    Google Scholar 

  8. Serruys PW, Suryapranata H, Piscione F, Harmsen E, Brand M, Feyter P, Hugenholtz PG, Jong JW (1989) Myocardial release of hypoxanthine and lactate during percutaneous transluminal coronary angioplasty. Am J Cardiol 63:45E-51E

    Google Scholar 

  9. He MX, Gorman MW, Roming GD, Sparks HV Jr (1992) Adenosine formation and myocardial energy status during graded hypoxia. J Moll Cell Cardiol 24:79–89

    Google Scholar 

  10. Smolenski RT, Suitters A, Yacoub M (1992) Adenine nucleotide catabolism and adenosine formation in isolated human cardiomyocytes. J Moll Cell Cardiol 24:91–96

    Google Scholar 

  11. Fox IH, Palella TD, Kelley WN (1987) Hyperuricemia: a marker for cell energy crisis. N Engl J Med 317:111–112

    Google Scholar 

  12. Ogino K, Kitamura H, Osaki S, Hisatome I, Miyakoda H, Matsumoto T, Noguchi N, Kinugawa T, Kotake H, Mashiba H (1993) Clinical significance of ammonia response during exercise in patients with congestive heart failure. Different implication from lactate response. J Am Coll Cardiol 21(Suppl):480A

    Google Scholar 

  13. Kosaka H, Hisatome I, Ogino K, Tanaka Y, Osaki S, Kitamura H, Omodani H, Matsumoto T, Miyakoda H, Kotake H, Mashiba H, Inoue A (1993) Excess purine degradation in muscle with chronic haemodialysis patients. Nephron 64:481–482

    Google Scholar 

  14. Ogino K, Kinugawa T, Noguchi N, Kitamura H, Matsumoto T, Miyakoda H Kotake H, Mashiba H. (1992) Suppression of sympathetic nervous system activity by Nicorandil during exercise. (1992) Gen Pharmacol 23:325–329

    Google Scholar 

  15. Andersson B, Blomström-Lundqvist C, Hedner T, Waagstein F (1991) Exercised hemodynamics and myocadial metabolism during long-term beta-blockade in severe heart failure. J Am Coll Cardiol 18:1059–1066

    Google Scholar 

  16. Borg GA (1982) Psychophysical bases of perceived exertion. Med Sci Sports Exercise 14:377–381

    Google Scholar 

  17. Kobayashi K, Hakuta T (1987) Effects of Nicorandil on coronary hemodynamics in ischemic heart disease: comparison with nitroglycerin, nifedipine, and propranolol. J Cardiovasc Pharmacol 10:S109-S115

    Google Scholar 

  18. Taira N (1989) Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol 63:18J-24J

    Google Scholar 

  19. Weiss RG, Bottomley PA, Hardy CJ, Gerstenblith G (1990) Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease. N Engl J Med 323:1593–1600

    Google Scholar 

  20. Lamping A, Christensen CW, Pelc LR, Warltier DC, Gross GJ (1984) Effects of nicorandil and nifedipine on protection of ischemic myocardium. J Cardiovasc Pharmacol 6:536–542

    Google Scholar 

  21. Pieper GM, Gross GJ (1987) Salutary action of Nicorandil, a new antianginal drug, on myocardial metabolism during ischemia and on postischemic function in a canine preparation of brief, repetitive coronary artery occlusions: comparison with isosorbide dinitrate. Circulation 76:916–28

    Google Scholar 

  22. Darby TD, Sprouse JH, Walton RP (1958) Evaluation of sympathetic reflex effects on the inotropic action of nitroglycerine, quinidine, papaverine, aminophylline, and isoproterenol. J Pharmacol Exp Ther 122:386–395

    Google Scholar 

  23. Nakaya H, Schwaltz A, Millard RW (1983) Reflex chronotropic and inotropic of calcium channel-blocking agents in conscious dogs. Circ Res 52:302–311

    Google Scholar 

  24. Thomas JA, Marks BH (1978) Plasma norepinephrine in congestive heart failure. Am J Cardiol. 41:233–243

    Google Scholar 

  25. Cohn JN, Levine TB, Olivari MT, Garberg V, Tura D, Francis GS, Simon AB, Rector T (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311:819–823

    CAS  PubMed  Google Scholar 

  26. Swedberg K, Viquerat C, Rouleau JL, Roizen M, Atherton B, Parmely WW, Chatterjee K (1984) Comparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without heart failure. Am J Cardiol 54:783–786

    Google Scholar 

  27. Kinoshita M, Nishikawa S, Sawamura M, Yamaguchi S, Mitsunami K, Itoh M, Motomura M, Bito K, Mashiro I, Kawakita S (1986) Comparative efficacy of high-dose versus low-dose Nicorandil therapy for chronic stable angina pectoris. Am J Cardiol 58:733–738

    Google Scholar 

  28. Watts JA, Norris TA, London RE, Steenbergen C, Murphy E (1990) Effects of diltiazem on lactate, ATP, and cytosolic free calcium levels in ischemic hearts. J Cardiovasc Pharmacol 15:44–49

    Google Scholar 

Download references

Author information

Author notes

  1. K. Ogino

    Present address: Department of Medicine, College of Physicians and Surgeons of Columbia University, 622 West 168th Street, 10032, New York, NY, USA

Authors and Affiliations

  1. The First Department of Internal Medicine, Tottori University School of Medicine, 683, Yonago, Japan

    K. Ogino, S. Osaki, N. Noguchi, H. Kitamura, H. Omodani, M. Kato, I. Hisatome, T. Matsumoto, T. Kinugawa, H. Miyakoda, H. Kotake & H. Mashiba

Authors
  1. K. Ogino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Osaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Noguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Kitamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Omodani
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Kato
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. I. Hisatome
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. T. Matsumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. T. Kinugawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. H. Miyakoda
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. H. Kotake
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. H. Mashiba
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ogino, K., Osaki, S., Noguchi, N. et al. Nicorandil suppressed myocardial purine metabolism during exercise in patients with angina pectoris. Eur J Clin Pharmacol 48, 189–194 (1995). https://doi.org/10.1007/BF00198297

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00198297

Key words

Search

Navigation